Contraception and pregnancy in microbicide trials

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 4, 2012, Pages 473-486

  Sibeko, Sengeziwe ^a   Cohen, Gabriel M ^a,b   Moodley, Jagidesa ^c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

contraception; HIV; microbicides; pregnancy

Indexed keywords

C 31G; CARBOPOL 974P; CARRAGEENAN; CELLULOSE SULFATE; CHORIONIC GONADOTROPIN BETA SUBUNIT; MICROBICIDE; NONOXINOL 9; ORAL CONTRACEPTIVE AGENT; PRO 2000; SAVVY; TENOFOVIR; UNCLASSIFIED DRUG;

CLINICAL TRIAL (TOPIC); CONDOM; CONTRACEPTION; COUNSELING; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; FEMALE; FEMALE INFERTILITY; FETUS MALFORMATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW DRUG DOSE; MEDICAL STAFF; PATIENT SAFETY; PERSONAL MONITORING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANCY TEST; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SELF REPORT; SEXUAL HEALTH; SPONTANEOUS ABORTION; STATISTICAL CONCEPTS; TERATOGENICITY;

EID: 84862903177     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2012.01.005     Document Type: Article

References (39)

1. UNAIDS. Report on the global AIDS epidemic update. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, 2008.
2. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990; 80: 460.
3. Padian N, McCoy SI, Balkus JE et al. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010; 24: 621.
4. Chirenje ZM, Marrazzo J. MTN-003 Protocol 2.0; 2010; http://www. mtnstopshiv.org/sites/default/files/attachments/MTN-003-FINAL-Version-2. 0-31DEC2010.pdf (last accessed 22 January 2012).
5. Facts Consortium: Working Together to Prevent HIV - facts 001 study [Internet]. [cited 2012 Feb 3]; Available from: http://www.facts-consortium.co. za/?page-id=83.
6. Raymond EG, Taylor D, Cates Jr.Wet al. Pregnancy in effectiveness trials of HIV prevention agents. Sex Transm Dis 2007; 34: 1035-1039. (Pubitemid 350158859)
7. Lagakos SW & Gable AR. Methodological challenges in biomedical HIV prevention trials. Washington, District of Columbia: National Academy of Sciences, 2008.
8. Smart T. High rates of pregnancy pose challenges for microbicide trials 2006, http://www.aidsmap.com/Microbicides-2006-High-rates-of-pregnancy-pose- challenges-for-microbicide-trials/page/1423789/ (last accessed 22 January 2012).
9. Peterson L, Nanda K, Opoku BK et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PloS One 2007; 2: e1312.
10. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168-1174.
11. Singh S, Sedgh G & Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann 2010; 41: 241-250.
12. Singh S, Darroch J & Ashford L. Meeting the need for modern family planning services. In: Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York, NY: Guttmacher Institute and United Nations Population Fund, 2009, pp. 16-20.
13. Kreiss JK, Ngugi E, Holmes K et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268: 477-482.
14. Roddy R, Zekeng L, Ryan KA et al. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-510. (Pubitemid 28384883)
15. Richardson BA, Lavreys L, Martin HL et al. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis 2001; 28: 394-400. (Pubitemid 32613682)
16. Van Damme L, Ramjee G, Alary M et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-977. (Pubitemid 35284107)
17. Van Damme L, Govinden R, Mirembe FM et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359: 463-472.
18. Halpern V, Ogunsola F, Obunge O et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PloS One 2008; 3: e3784.
19. Mauck CK, Freziers RG, Walsh TL et al. Noncomparative contraceptive efficacy of cellulose sulfate gel. Obstet Gynecol 2008; 111: 739.
20. Feldblum PJ, Adeiga A, Bakare R et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PloS One 2008; 3: e1474.
21. National Institutes of Health (NIH). Pregnancy and Contraception in Microbicide Development Meeting. March 2009; http://www.nichd.nih.gov/about/ meetings/2009/031009.cfm. (last accessed 22 January 2012)
22. Sibeko S, Baxter C, Yende N et al. Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol 2011; 118: 895-904.
23. Trussell J. Contraceptive failure in the United States. Contraception 2004; 70: 89-96. (Pubitemid 38993483)
24. Abdool Karim SS, Richardson BA, Ramjee G et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; 25: 957-966.
25. Skoler-Karpoff S, Ramjee G, Ahmed K et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1977-1987.
26. McCormack S, Ramjee G, Kamali A et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376: 1329-1337.
27. Cele N, Palanee T, Myeni N et al. Impact of provision of hormonal contraception on pregnancy incidence in women enrolled in the phase 3 Carraguard clinical trial at three sites in South Africa 2008, http://www.popcouncil.org/ pdfs/Microbicides2008/Cele-Poster.pdf (last accessed 22 January 2012).
28. Chisembele M. Pregnancy and contraception in microbicide development - Zambia MDP. In: Pregnancy and Contraception in Microbicide Development. Washington, DC: NIH, 2009.
29. Tsui AO, McDonald-Mosley R & Burke AE. Family planning and the burden of unintended pregnancies. Epidemiol Rev 2010; 32: 152-174.
30. Westoff CF. DHS Analytical Studies No. 8: recent trends in abortion and contraception in 12 Countries. Calverton, Maryland: ORC Macro, 2005.
31. Halpern V, Lie C-C, Feldblum PJ et al. Predictors of pregnancy in microbicide trials. Contraception 2011; 83: 436-440.
32. Blanchard K, Bostrom A, Montgomery E et al. Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. Contraception 2011; 83: 556-563.
33. Schreiber CA, Sammel M, Hillier SL et al. A little bit pregnant: modeling how the accurate detection of pregnancy can improve HIV prevention trials. Am J Epidemiol 2009; 169: 515.
34. Gray RH, Li X, Kigozi G et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366: 1182-1188. (Pubitemid 41393596)
35. Wilcox AJ, Dunson DB, Weinberg CR et al. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception 2001; 63: 211-215. (Pubitemid 32480203)
36. Friedland B. Pregnancy/Contraception in Carraguard Phase 3 Trial. In: Pregnancy and Contraception in Microbicide Development. Washington, DC: NIH, 2009.
37. Abdool Karim SS. HPTN 035 Protocol 3.0 2007, http://www.mtnstopshiv.org/ sites/default/files/attachments/HPTN035v3.pdf (last accessed 22 January 2012).
38. Global Campaign for Microbicides (GCM). GCM Advocates Call on HPTN 035 Results Wednesday 11th February at 9AM EST, 2009; http://www.global-campaign. org/clientfiles/HPTN 035 Results Release Advocates Call Notes.pdf (last accessed 22 January 2012).
39. Morrison CS, Skoler-Karpoff S, Kwok C et al. Hormonal Contraception and the Risk of HIV Acquisition among Women in South Africa. AIDS 2012; 25: 1-8.